Autolus Therapeutics plc (AUTL) stock
AUTLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/3020% below fair value
$1.06−0.03 (-2.75%)
Close on Nov 18, 2026Market cap $282.13MP/E –Yield –
Autolus Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Autolus Therapeutics's total debt was $380.00K at Sep 30, 2018. For fiscal 2018 it was $380.00K, down 50.2% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $380.00K | -50.2% |
| FY2017 | Sep 30, 2017 | $763.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $380.00K | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $763.00K | – |
See a number that looks wrong?